TD

The Duke of Bedford

Description

The Duke of Bedford

Investor Profile

The Duke of Bedford has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Therapeutics.

Stage Focus

  • Series Unknown (67%)
  • Seed (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Duke of Bedford frequently co-invest with?

Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 2
Good Growth Capital
North America, South Carolina, United States, Charleston
Co-Investments: 2
ShangPharma Innovation
North America, California, United States, San Francisco
Co-Investments: 1
GreatPoint Ventures
North America, Michigan, United States, New Haven
Co-Investments: 1

Which angels does The Duke of Bedford often collaborate with?

Shared Deals: 2

What are some of recent deals done by The Duke of Bedford?

Skyhawk Therapeutics

Waltham, Massachusetts, United States

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

BiotechnologyTherapeutics
Series UnknownJun 26, 2018
Amount Raised: $40,000,000
Skyhawk Therapeutics

Waltham, Massachusetts, United States

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

BiotechnologyTherapeutics
SeedJan 23, 2018
Amount Raised: $8,000,000
Dragonfly Therapeutics

Waltham, Massachusetts, United States

Dragonfly Therapeutics is a clinical-stage biotech developing novel immunotherapies that harness the innate immune system to treat disease.

BiotechnologyTherapeutics
Series UnknownMay 15, 2017

Find More Investors Like The Duke of Bedford

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

The Duke of Bedford | Pipeseed